Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy

Protein structure prediction on the Web: a case study using the Phyre server

Kelley, L. A., & Sternberg, M. J. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.2 · Cited by 4,154

CD44 is the principal cell surface receptor for hyaluronate

Aruffo, A. A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,439

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195

Hyaluronan: its nature, distribution, functions and turnover.

Fraser, J. R. E., Laurent, T. C., & Laurent, U. B. G. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00170.x · Cited by 2,031

Angiogenesis Induced by Degradation Products of Hyaluronic Acid

West, D. C., HAMPSON, I. N., Arnold, F., & Kumar, S. (1985) · Science · doi:10.1126/science.2408340 · Cited by 1,140

Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme

Camenisch, T. D., Spicer, A. P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M. L., Calabro, A., Kubalak, S., Klewer, S. E., & McDonald, J. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10272 · Cited by 901

Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties

Itano, N., Sawai, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., Shinomura, T., Hamaguchi, M., Yoshida, Y., Ohnuki, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25085 · Cited by 901

Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation

Webber, J. P., Steadman, R., Mason, M. D., Tabi, Z., & Clayton, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1722 · Cited by 899

High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat

Tian, X., Azpurua, J., Hine, C., Vaidya, A. M., Myakishev-Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V. A., & Seluanov, A. (2013) · Nature · doi:10.1038/nature12234 · Cited by 786

Role of Extracellular Matrix in Development and Cancer Progression

Walker, C., Mojares, E., & Hernández, A. E. D. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103028 · Cited by 1,151

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073

3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages

Habanjar, O., Diab‐Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212200 · Cited by 590

Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application

Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 497

Hyaluronan biology: A complex balancing act of structure, function, location and context

Garantziotis, S., & Savani, R. C. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.02.002 · Cited by 400

Development and application of hyaluronic acid in tumor targeting drug delivery

Luo, Z., Dai, Y., & Gao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.004 · Cited by 379

Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics

Karamanos, N. K., Piperigkou, Z., Theocharis, A. D., Watanabe, H., Franchi, M., Baud, S., Brézillon, S., Götte, M., Passi, A. G., Vigetti, D., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00354 · Cited by 380

Graphene‐Based Smart Platforms for Combined Cancer Therapy

Gu, Z., Zhu, S., Yan, L., Zhao, F., & Zhao, Y. (2018) · Advanced Materials · doi:10.1002/adma.201800662 · Cited by 338

Hyaluronic Acid–Based Activatable Nanomaterials for Stimuli‐Responsive Imaging and Therapeutics: Beyond CD44‐Mediated Drug Delivery

Choi, K. Y., Han, H. S., Lee, E. S., Shin, J. M., Almquist, B. D., Lee, D. S., & Park, J. H. (2019) · Advanced Materials · doi:10.1002/adma.201803549 · Cited by 320

Hyaluronan as a therapeutic target in human diseases

Liang, J., Jiang, D., & Noble, P. W. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.017 · Cited by 245

Tumor microenvironment responsive drug delivery systems

He, Q., Chen, J., Yan, J., Cai, S., Xiong, H., Liu, Y., Peng, D., Mo, M., & Liu, Z. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.08.003 · Cited by 223

Transposable Elements in Human Cancer: Causes and Consequences of Deregulation

Anwar, S. L., Wulaningsih, W., & Lehmann, U. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050974 · Cited by 209

Tumor Abnormality-Oriented Nanomedicine Design

Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 203

Hyaluronan – A Functional and Structural Sweet Spot in the Tissue Microenvironment

Monslow, J., Govindaraju, P. K., & Puré, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00231 · Cited by 184

Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms

Kaushik, N., Borkar, S. B., Nandanwar, S., Panda, P. K., Choi, E. H., & Kaushik, N. K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01364-2 · Cited by 190

Hyaluronic Acid: Incorporating the Bio into the Material

Wolf, K. J., & Kumar, S. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01268 · Cited by 178

Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations

Pawłowska, E., Szczepańska, J., & Błasiak, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7286737 · Cited by 178

Physical biology of the cancer cell glycocalyx

Kuo, J. C., Gandhi, J. G., Zia, R. N., & Paszek, M. J. (2018) · Nature Physics · doi:10.1038/s41567-018-0186-9 · Cited by 165

Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment

Liu, M., Tölg, C., & Turley, E. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00947 · Cited by 161

Nanogels for intracellular delivery of biotherapeutics

Li, D., van Nostrum, C. F., Mastrobattista, E., Vermonden, T., & Hennink, W. E. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.020 · Cited by 161

Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery

Dolor, A., & Szoka, F. C. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00319 · Cited by 147

Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment

Marozzi, M., Parnigoni, A., Negri, A., Viola, M., Vigetti, D., Passi, A. G., Karousou, E. G., & Rizzi, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158102 · Cited by 144

Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression

McCarthy, J. B., El‐Ashry, D., & Turley, E. A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00048 · Cited by 130

How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?

Cong, V. T., Houng, J. L., Kavallaris, M., Chen, X., Tilley, R. D., & Gooding, J. J. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00707f · Cited by 129

Oncolytic viruses: overcoming translational challenges

Martínez‐Quintanilla, J., Seah, I. Y. J., Chua, M. M. J., & Shah, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122287 · Cited by 122

Responsive crosslinked polymer nanogels for imaging and therapeutics delivery

Ekkelenkamp, A. E., Elzes, M. R., Engbersen, J. F. J., & Paulusse, J. M. J. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02239e · Cited by 121

Towards extracellular matrix normalization for improved treatment of solid tumors

Abyaneh, H. S., Regenold, M., McKee, T. D., Allen, C. J., & Gauthier, M. A. (2020) · Theranostics · doi:10.7150/thno.39995 · Cited by 120

Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment

Wong, K. H., Lü, A., Chen, X., & Yang, Z. (2020) · Molecules · doi:10.3390/molecules25163620 · Cited by 122

Cancer Microenvironment and Inflammation: Role of Hyaluronan

Nikitovic, D., Tzardi, M. N., Berdiaki, A., Tsatsakis, A. M., & Tzanakakis, G. N. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00169 · Cited by 114

Extracellular matrix proteomics in schizophrenia and Alzheimer’s disease

Sethi, M. K., & Zaia, J. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9900-6 · Cited by 113

Hyaluronan as tunable drug delivery system

Passi, A. G., & Vigetti, D. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.08.006 · Cited by 113

Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents

He, H., Sun, L., Ye, J., Liu, E., Chen, S., Liang, Q., Shin, M. C., & Yang, V. C.-M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.040 · Cited by 111

Cell Energy Metabolism and Hyaluronan Synthesis

Caon, I., Parnigoni, A., Viola, M., Karousou, E. G., Passi, A. G., & Vigetti, D. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420929772 · Cited by 112

Charge‐Reversible Nanoparticles: Advanced Delivery Systems for Therapy and Diagnosis

Veider, F., Armengol, E. S., & Bernkop‐Schnürch, A. (2023) · Small · doi:10.1002/smll.202304713 · Cited by 113

Activatable Phototheranostic Materials for Imaging-Guided Cancer Therapy

Cheng, P., & Pu, K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15064 · Cited by 107

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Jurj, A. M., Ionescu, C., Berindan‐Neagoe, I., & Braicu, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02484-1 · Cited by 113

Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review

Michalczyk, M., Humeniuk, E., Adamczuk, G., & Korga-Plewko, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010103 · Cited by 106

A Novel Multimodal NIR-II Nanoprobe for the Detection of Metastatic Lymph Nodes and Targeting Chemo-Photothermal Therapy in Oral Squamous Cell Carcinoma

Wang, Y., Zhang, W., Sun, P., Cai, Y., Xu, W., Fan, Q., Hu, Q., & Han, W. (2019) · Theranostics · doi:10.7150/thno.30268 · Cited by 97

Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance

Price, Z. K., Lokman, N. A., & Ricciardelli, C. (2018) · Cancers · doi:10.3390/cancers10120482 · Cited by 100

Inorganic Nanomaterial‐Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities

Lin, G., Revia, R. A., & Zhang, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202007096 · Cited by 97

Characterization of the tumor microenvironment and tumor–stroma interaction by non-invasive preclinical imaging

Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93

A Trickster in Disguise: Hyaluronan’s Ambivalent Roles in the Matrix

Bohaumilitzky, L., Huber, A., Stork, E. M., Wengert, S., Woelfl, F., & Boehm, H. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00242 · Cited by 94

Glycosylation and Cancer: Moving Glycomics to the Forefront

Drake, R. R. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.12.002 · Cited by 90

The DNMT1-PAS1-PH20 axis drives breast cancer growth and metastasis

Fu, Y., Zhang, X., Liu, X., Wang, P., Chu, W., Zhao, W., Wang, Y., Zhou, G., Yu, Y., & Zhang, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00896-1 · Cited by 88

CD147

Grass, G. D., Dai, L., Qin, Z., Parsons, C. H., & Toole, B. P. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00013-7 · Cited by 82

Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview

Kapalatiya, H., Madav, Y., Tambe, V. S., & Wairkar, S. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01020-6 · Cited by 81

Carcinoma Cell Hyaluronan as a “Portable” Cancerized Prometastatic Microenvironment

Turley, E. A., Wood, D. K., & McCarthy, J. B. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3114 · Cited by 71

Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases

Rao, N. V., Rho, J. G., Um, W., Ek, P. K., Nguyen, V. Q., Oh, B. H., Kim, W., & Park, J. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100931 · Cited by 79

pH-responsive hyaluronic acid-based nanoparticles for targeted curcumin delivery and enhanced cancer therapy

Lai, H., Ding, X., Ye, J., Deng, J., & Cui, S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111455 · Cited by 76

Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets

Lu, J., Zhao, Z., Pan, L., Wu, H. C., Wang, S., Tong, X., & Wu, S. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00299-y · Cited by 82

Hyaluronan in adipogenesis, adipose tissue physiology and systemic metabolism

Zhu, Y., Kruglikov, I. L., Akgul, Y., & Scherer, P. E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2018.02.012 · Cited by 68

Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling

McAtee, C. O., Booth, C. S., Elowsky, C. G., Zhao, L. Q., Payne, J., Fangman, T., Caplan, S., Henry, M. D., & Simpson, M. A. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.002 · Cited by 72

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets

Morera, D. S., Hennig, M., Talukder, A. M., Lokeshwar, S. D., Wang, J., Garcia-Roig, M. L., Ortiz, N., Yates, T. J., López, L. E., Kallifatidis, G., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.318 · Cited by 71

A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis

Sugahara, K. N., Scodeller, P., Braun, G. B., de Mendoza, T. H., Yamazaki, C. M., Kluger, M. D., Kitayama, J., Alvarez, E. A., Howell, S. B., Teesalu, T., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.009 · Cited by 71

Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells

Mesquita, A. P. D. S., Lopes, S. D. A., Filho, P. C. A. P., Nader, H. B., & Lopes, C. C. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1392-0 · Cited by 68

Strategies for Glycoengineering Therapeutic Proteins

Dammen‐Brower, K., Epler, P., Zhu, S. E., Bernstein, Z. J., Stabach, P. R., Braddock, D. T., Spangler, J. B., & Yarema, K. J. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.863118 · Cited by 70

Targets of tumor microenvironment for potential drug development

Zhang, L., Wang, Z., Liu, K., Liu, Y., Wang, S., Jiang, W., Lu, F., & Dang, Y. (2024) · MedComm – Oncology · doi:10.1002/mog2.68 · Cited by 68

Tumor microenvironment and nanotherapeutics: intruding the tumor fort

Kiran, A. V. V. V. R., Kumari, G. K., Krishnamurthy, P. T., & Khaydarov, R. R. (2021) · Biomaterials Science · doi:10.1039/d1bm01127h · Cited by 61

Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation

Carvalho, A. M., da Costa, D. S., Paulo, P. M. R., Reis, R. L., & Pashkuleva, I. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.10.024 · Cited by 57

Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics

Sreepadmanabh, M., & Toley, B. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.009 · Cited by 58

Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?

Machado, V., Morais, M., & Medeiros, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102092 · Cited by 53

Tumor-Microenvironment- Responsive Size-Shrinkable Drug-Delivery Nanosystems for Deepened Penetration Into Tumors

Cheng, X., Li, H., Ge, X., Chen, L., Liu, Y., Mao, W., Zhao, B., & Yuan, W. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.576420 · Cited by 50

Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy

Lin, M., & Qi, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051450 · Cited by 52

Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy

Berdiaki, A., Neagu, M. T., Giatagana, E.-M., Николаевич, К. А., Tsatsakis, A. M., Tzanakakis, G. N., & Nikitovic, D. (2021) · Biomolecules · doi:10.3390/biom11030395 · Cited by 50

Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure–activity relationship

Gębalski, J., Graczyk, F., & Załuski, D. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2061966 · Cited by 49

Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems

Sethuraman, V., Janakiraman, K., Krishnaswami, V., & Kandasamy, R. (2021) · Current Drug Targets · doi:10.2174/1389450122999210128180058 · Cited by 49

Neomenthol prevents the proliferation of skin cancer cells by restraining tubulin polymerization and hyaluronidase activity

Fatima, K., Masood, N., Wani, Z. A., Meena, A., & Luqman, S. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.003 · Cited by 46

Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides

Behzadipour, Y., & Hemmati, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116910 · Cited by 45

Comparative study of GC‐MS characterization, antioxidant activity and hyaluronidase inhibition of different species of Lavandula and Thymus essential oils

Carrasco, A., Pérez‐Ruiz, T., Tudela, J., & Miguel, M. G. (2015) · Flavour and Fragrance Journal · doi:10.1002/ffj.3283 · Cited by 44

Insights into the source, mechanism and biotechnological applications of hyaluronidases

Zhang, Y.-S., Gong, J., Yao, Z.-Y., Jiang, J., Su, C., Li, H., Kang, C.-L., Liu, L., Xu, Z., & Shi, J. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.108018 · Cited by 43

Quercetin liposomes conjugated with hyaluronidase: An efficient drug delivery system to block pancreatic cancer

Sun, G., Wu, Y., Li, J., Yang, M., Xu, H., Li, Y., Tong, P., Shao, R., Liu, Y., & Kong, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113642 · Cited by 44

Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice

Zhang, B., Jiang, T., She, X., Shen, S., Wang, S., Deng, J., Shi, W., Mei, H., Hu, Y., Pang, Z., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.015 · Cited by 44

Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling

Nichols, J. W., Sakurai, Y., Harashima, H., & Bae, Y. H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.003 · Cited by 44

Targeting the lysyl oxidases in tumour desmoplasia

Chitty, J. L., Setargew, Y. F. I., & Cox, T. R. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190098 · Cited by 41

Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment

Peng, Y., Bariwal, J. B., Kumar, V., Tan, C., & Mahato, R. I. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900136 · Cited by 44

Hyaluronan activates Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed

Hsu, L., Hong, Q., Chen, S.-T., Kuo, H.-L., Schultz, L., Heath, J., Lin, S., Lee, M.-H., Li, D.-Z., Li, Z.-L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13268 · Cited by 39

Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects

Avenoso, A., D’Ascola, A., Scuruchi, M., Mandraffino, G., Calatroni, A., Saitta, A., Campo, S., & Campo, G. M. (2017) · Inflammation Research · doi:10.1007/s00011-017-1084-9 · Cited by 41

Enzyme-Assisted Photodynamic Therapy Based on Nanomaterials

Du, B., & Tung, C. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00968 · Cited by 39

Metastatic Breast Cancer: Review of Emerging Nanotherapeutics

Dissanayake, R. K., Towner, R. A., & Ahmed, M. (2023) · Cancers · doi:10.3390/cancers15112906 · Cited by 37

Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression

Das, A., Mohan, V., Krishnaswamy, V. R., Solomonov, I., & Sagi, I. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09813-5 · Cited by 37

Hyaluronidase Hyal1 Increases Tumor Cell Proliferation and Motility through Accelerated Vesicle Trafficking

McAtee, C. O., Berkebile, A. R., Elowsky, C. G., Fangman, T., Barycki, J. J., Wahl, J. K., Khalimonchuk, O., Naslavsky, N., Caplan, S., & Simpson, M. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647446 · Cited by 36

Recent advances in nanocarriers-based drug delivery for cancer therapeutics: A review

Yadav, P., Jain, J., & Sherje, A. P. (2021) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2021.104970 · Cited by 37

Equilibrium Modeling of the Mechanics and Structure of the Cancer Glycocalyx

Gandhi, J. G., Koch, D. L., & Paszek, M. J. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2018.12.023 · Cited by 38

Evolution of high-molecular-mass hyaluronic acid is associated with subterranean lifestyle

Zhao, Y., Zheng, Z., Zhang, Z., Xu, Y., Hillpot, E., Lin, Y. S., Zakusilo, F. T., Lu, J. Y., Ablaeva, J., Biashad, S. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43623-2 · Cited by 34

Sporothriolide-Related Compounds from the Fungus Hypoxylon monticulosum CLL-205 Isolated from a Sphaerocladina Sponge from the Tahiti Coast

Leman-Loubière, C., Goff, G. L., Retailleau, P., Debitus, C., & Ouazzani, J. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00714 · Cited by 33

Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis

Kouvidi, K., Berdiaki, A., Tzardi, M. N., Karousou, E. G., Passi, A. G., Nikitovic, D., & Tzanakakis, G. N. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.019 · Cited by 34

WNT5B drives osteosarcoma stemness, chemoresistance and metastasis

Perkins, R. S., Murray, G., Suthon, S., Davis, L., Perkins, N. B., Fletcher, L. B., Bozzi, A., Schreiber, S. L., Lin, J., Laxton, S. J., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1670 · Cited by 30

Oil-in-microgel strategy for enzymatic-triggered release of hydrophobic drugs

Busatto, C. A., Labie, H., Lapeyre, V., Auzély‐Velty, R., Perro, A., Casís, N., Luna, J. A., Estenoz, D. A., & Ravaine, V. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.01.029 · Cited by 31

A guide to hyaluronan and related enzymes in breast cancer: biological significance and diagnostic value

Velesiotis, C., Vasileiou, S., & Vynios, D. H. (2019) · FEBS Journal · doi:10.1111/febs.14860 · Cited by 33

Cirsimaritin, a lung squamous carcinoma cells (NCIH-520) proliferation inhibitor

Pathak, G., Singh, S., Kumari, P., Raza, W., Hussain, Y., & Meena, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763198 · Cited by 32

Tumor Microenvironment-Responsive Nanomaterials as Targeted Delivery Carriers for Photodynamic Anticancer Therapy

Liu, H., Jiwen, Y., Guo, H., Cai, X., Jiang, Y., Lin, M., Jiang, X., Leung, W., & Xu, C. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00758 · Cited by 31

Halting hyaluronidase activity with hyaluronan-based nanohydrogels: development of versatile injectable formulations

Montanari, E., Zoratto, N., Mosca, L., Cervoni, L., Lallana, E., Angelini, R., Matassa, R., Coviello, T., Meo, C. D., & Matricardi, P. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.06.004 · Cited by 30

The CD147‐HYALURONAN Axis in Cancer

Toole, B. P. (2019) · The Anatomical Record · doi:10.1002/ar.24147 · Cited by 30

Nanomedicines with high drug availability and drug sensitivity overcome hypoxia-associated drug resistance

Liu, Y., Dong, W., Ma, Y., Dou, J., Jiang, W., Wang, L., Wang, Q., Li, M., Wang, Y., & Li, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122023 · Cited by 30

Cirsilineol inhibits proliferation of lung squamous cell carcinoma by inducing ROS mediated apoptosis

Pathak, G., Singh, S., Kumari, P., Hussain, Y., Raza, W., Luqman, S., & Meena, A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111550 · Cited by 28

Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer

Jordan, A. R., Lokeshwar, S. D., López, L. E., Hennig, M. J. P., Chipollini, J. J., Yates, T. J., Hupe, M. C., Merseburger, A. S., Shiedlin, A., Cerwinka, W. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10529 · Cited by 29

Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation

Kohi, S., Sato, N., Koga, A., Hirata, K., Harunari, E., & Igarashi, Y. (2016) · Journal of Oncology · doi:10.1155/2016/9063087 · Cited by 29

Design Strategies for Hyaluronic Acid-based Drug Delivery Systems in Cancer Immunotherapy

Rodella, G., Véronique Préat, A., Gallez, B., & Malfanti, A. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113784 · Cited by 28

Vitamin C: A stem cell promoter in cancer metastasis and immunotherapy

Fu, J., Wu, Z., Liu, J., & Wu, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110588 · Cited by 28

The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems

Foglietta, F., Serpe, L., & Canaparo, R. (2021) · Cells · doi:10.3390/cells10123295 · Cited by 27

Hyaluronan metabolism: a major paradox in cancer biology

Stern, R. (2005) · Pathologie Biologie · doi:10.1016/j.patbio.2004.12.021 · Cited by 164

Hyaluronidases in tissue invasion.

Csóka, T. B., Frost, G. I., Stern, R., & Csoka, A. B. (1997) · PubMed · Cited by 102

Hyaluronidases in Cancer Biology

Stern, R. (2008) · Elsevier eBooks · doi:10.1016/b978-012374178-3.10012-2 · Cited by 39

Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses

Menzel, E. J., & Farr, C. V. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00195-5 · Cited by 347

Hyaluronidase as a Therapeutic Target in Cancer: A Matter of Too Little or Too Much

(2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.9.2098 · Cited by 2